First patient dosed in phase II Telix Starburst trial
The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin...Read more on AuntMinnie.comRelated Reading:
Telix acquires Dedicaid for $1.2M
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results
Telix relocates U.S. headquarters
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news